The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brigatinib in pretreated patients with ALK-positive advanced NSCLC.
 
Renaud Descourt
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche; Takeda
Research Funding - Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche; Takeda
 
Maurice Perol
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Gaelle Rousseau-Bussac
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Lilly; MSD; Mundipharma; Novartis; Pfizer; Roche; Takeda
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MedImmune; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Bertrand Mennecier
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Pierre Fabre; Roche/Genentech; Vifor Pharma
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD (Inst); novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Expert Testimony - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Marie Wislez
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Roche
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Alexis B. Cortot
Honoraria - Bristol-Myers Squibb; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Pfizer; Roche
Research Funding - Merck Serono (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Florian Guisier
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Pfizer (Inst)
 
Radj Gervais
No Relationships to Disclose
 
Loick Galland
No Relationships to Disclose
 
Roland Schott
Honoraria - Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Pierre Fabre; Roche; Takeda
 
Eric Dansin
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Jennifer ARRONDEAU
Travel, Accommodations, Expenses - Pfizer
 
Jean-Bernard Auliac
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Christos Chouaid
Honoraria - Roche, Amgen, BMS, MSD, AZ, BI, Novartis, Pfizer, Takeda
Consulting or Advisory Role - Roche, MSD, BMS, AZ,; Roche, MSD, BMS, AZ,
Research Funding - AZ, BMS, MSD, PF, Takeda, Pfizer, Novartis, Roche (Inst)
Travel, Accommodations, Expenses - AZ, Roche, Pfizer, MSD, BMS, BI; AZ, Roche, Pfizer, MSD, BMS, BI